Research has identified microRNAs as potential biomarkers for predicting COVID-19-related mortality in patients with cancer.

A study revealed highly specific gut microbiome signatures for NAFLD, using machine learning to differentiate the disease ...

Discover a recent study that has provided valuable insights into the experiences of Latine patients living with moderate to ...

A new study highlights the complexities of psychedelic-assisted psychotherapy, focusing on therapist factors, patient ...

Mpox outbreaks reveal gaps in global vaccine coverage and infectious disease preparedness. Learn how recent research ...

Recall matters when it comes to medical content. Find out how knowledge can be better retained through interactive medical ...

Vitamin D deficiency is strongly associated with an increased risk of severe acute exacerbations in patients with chronic ...

Study finds that ultrafast MRI-based radiomics model performs just as well as standard MRI in classifying breast cancer ...

A new study has identified pathogenic variants in WNT9B as significant risk factors for hereditary prostate cancer. Read more ...

A novel biomarker signature can classify pain sensitivity, offering potential for early intervention and improved chronic ...

The world’s first chikungunya vaccine, developed by French pharmaceutical firm Valneva SE, has been approved in the UK by the ...

Discover how high-content imaging identifies drug responses and disease activity in rheumatoid arthritis, paving the way for personalized treatments.